Literature DB >> 7598499

Cytochromes P450 expression systems.

F J Gonzalez1, K R Korzekwa.   

Abstract

Catalytically active cytochrome P450 enzymes have been successfully expressed in bacterial, yeast, and mammalian cells. A variety of expression vectors have been used, resulting in both transient and stable expression. The system of choice depends on the goals of a particular project. Factors such as expense, ease of use, and yields required should govern the decision whether to use bacterial, yeast, insect, or mammalian cDNA expression. High-level expression of mammalian P450s in bacteria usually requires modifications of the amino-terminal region of the enzyme. The Escherichia coli P450-OR fusion proteins may also come of age for use in fermentation-production processes for the chemical industry. Many cytochromes P450 have been expressed in yeast, with variable levels of expression. Baculovirus, albeit somewhat tedious in having to individualize expression conditions, can produce high levels of enzyme. The standard mammalian cell expression systems, both transient and stable, have been of tremendous value to drug metabolism and carcinogenesis research and will continue to play a role in these areas.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7598499     DOI: 10.1146/annurev.pa.35.040195.002101

Source DB:  PubMed          Journal:  Annu Rev Pharmacol Toxicol        ISSN: 0362-1642            Impact factor:   13.820


  18 in total

Review 1.  Cytochrome P450 humanised mice.

Authors:  Frank J Gonzalez
Journal:  Hum Genomics       Date:  2004-05       Impact factor: 4.639

2.  Pharmacogenomic Next-Generation DNA Sequencing: Lessons from the Identification and Functional Characterization of Variants of Unknown Significance in CYP2C9 and CYP2C19.

Authors:  Sandhya Devarajan; Irene Moon; Ming-Fen Ho; Nicholas B Larson; Drew R Neavin; Ann M Moyer; John L Black; Suzette J Bielinski; Steven E Scherer; Liewei Wang; Richard M Weinshilboum; Joel M Reid
Journal:  Drug Metab Dispos       Date:  2019-02-11       Impact factor: 3.922

3.  Development of HepG2-derived cells expressing cytochrome P450s for assessing metabolism-associated drug-induced liver toxicity.

Authors:  Jiekun Xuan; Si Chen; Baitang Ning; William H Tolleson; Lei Guo
Journal:  Chem Biol Interact       Date:  2015-10-22       Impact factor: 5.192

4.  Comparison of microbial hosts and expression systems for mammalian CYP1A1 catalysis.

Authors:  Sjef Cornelissen; Mattijs K Julsing; Andreas Schmid; Bruno Bühler
Journal:  J Ind Microbiol Biotechnol       Date:  2011-08-24       Impact factor: 3.346

5.  Heterologous expression and characterization of plant Taxadiene-5α-Hydroxylase (CYP725A4) in Escherichia coli.

Authors:  John Edward Rouck; Bradley Walters Biggs; Amogh Kambalyal; William R Arnold; Marjan De Mey; Parayil Kumaran Ajikumar; Aditi Das
Journal:  Protein Expr Purif       Date:  2017-01-18       Impact factor: 1.650

6.  Molecular cloning and recombinant expression of cytochrome P450 CYP6B6 from Helicoverpa armigera in Escherichia coli.

Authors:  Xiaoning Liu; Lei Zhang; Xuetao Zhang; Gao Xiwu
Journal:  Mol Biol Rep       Date:  2012-10-25       Impact factor: 2.316

7.  Quantitative drug interactions prediction system (Q-DIPS): a dynamic computer-based method to assist in the choice of clinically relevant in vivo studies.

Authors:  P Bonnabry; J Sievering; T Leemann; P Dayer
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

8.  Expression and functional characterization of cytochrome P450 26A1, a retinoic acid hydroxylase.

Authors:  Justin D Lutz; Vaishali Dixit; Catherine K Yeung; Leslie J Dickmann; Alex Zelter; Jayne E Thatcher; Wendel L Nelson; Nina Isoherranen
Journal:  Biochem Pharmacol       Date:  2008-10-17       Impact factor: 5.858

9.  Modifications in the N-terminus of an insect cytochrome P450 enhance production of catalytically active protein in baculovirus-Sf9 cell expression systems.

Authors:  Wenfu Mao; May R Berenbaum; Mary A Schuler
Journal:  Insect Biochem Mol Biol       Date:  2007-09-26       Impact factor: 4.714

Review 10.  Cytochrome P450 enzymes and drug metabolism--basic concepts and methods of assessment.

Authors:  P Glue; R P Clement
Journal:  Cell Mol Neurobiol       Date:  1999-06       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.